FDA DEVICE FACTS
Halo AF Detection System
Livmor
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The LIVMOR Halo AF Detection SystemTM is indicated for use by patients who have been diagnosed with or are susceptible to developing atrial fibrillation and who would like to monitor and record their pulse rhythms on an intermittent basis so that their physician can be alerted of detected irregular heart rhythms. The LIVMOR Halo AF Detection System is intended for use in conjunction with the LIVMOR Halo+ Home Monitoring SystemTM, and is not validated for use with other pulse monitoring systems.
COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH PREDICATE DEVICE The LIVMOR Halo AF Detection System has the same intended use, technological characteristics, and principles of operation as its predicate device, FibriCheck. The minor differences between the LIVMOR device and its predicate device do not raise new questions of safety or effectiveness.
The LIVMOR Halo AF Detection was evaluated for sensitivity and specificity in the intended use subjects. The primary differences between the LIVMOR Halo AF Detection System and predicate are:
• Duration of recording LIVMOR Halo AF Detection System analyses data recorded for a duration of hours automatically each night, and for periods of 10 minutes on patient initiation, with patient at rest, whilst Predicate records for 1 minute on patient initiation with patient at rest.
• Delivery of result - The LIVMOR AF Detection System results are delivered to the overseeing physician through the LIVMOR HeartView Physician Web Portal, whilst the Predicate delivers AF detection results direct to the patient
Device Name LIVMOR Halo AF Detection System FibriCheck 510(k) Number K201208 K173872 Manufacturer LIVMOR Qompium Regulation 870.2920 870.2920 Device Classification Name Telephone electrocardiograph transmitter and receiver Telephone electrocardiograph transmitter and receiver Product Code DXH DXH Indication Statement The LIVMOR Halo AF Detection SystemTM is indicated for use by patients who have been diagnosed with or are susceptible to developing atrial fibrillation and who would like to monitor and record their pulse rhythms on an intermittent basis so that their physician can be alerted of detected irregular heart rhythms. The LIVMOR Halo AF Detection System is intended for use in conjunction with the LIVMOR Halo+ Home Monitoring SystemTM, and is not validated for use with other pulse monitoring systems. FibriCheck is indicated for self-testing by patients who have been diagnosed with, or are susceptible to developing, atrial fibrillation and who would like to monitor and record their heart rhythms on an intermittent basis. Intended User Adult Adult Prescription device for home use Yes Yes Single patient use Yes Yes Monitors regularity of heartbeat Yes Yes LIVMOR Halo AF Detection SystemTM K201208 Device Name LIVMOR Halo AF Detection System FibriCheck Alerts user to irregular rhythm Physician would consult with the patient if AF is suggested. User is notified when AF is detected and prompted to follow up with a physician. Device design LIVMOR Halo AF Detection System obtains PPG waveform via a smart watch and transmits to HeartView portal when connected to Wifi FibriCheck obtains PPG waveform via mobile phone camera and displays signal in real time on the mobile phone with an arrhythmia index. User Interface Web portal Web portal AF Detection Functionality & Performance Per Subject (n=92) Sensitivity: 100% Specificity: 93.0% Per Measurement (n=1834) Sensitivity: 93.3% Specificity: 99.1% Per Subject (n=223) Sensitivity: 95.6% Specificity: 96.6% Per Measurement (n=547) Sensitivity: 95.3% Specificity: 96.2%
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。